人类免疫缺陷病毒感染患者中的脂蛋白90K：疾病进展的又一血清学标志物。 - Suppr

Suppr

超能文献

Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression.

作者信息

Iacobelli S, Natoli C, D'Egidio M, Tamburrini E, Antinori A, Ortona L

出版信息

J Infect Dis. 1991 Oct;164(4):819. doi: 10.1093/infdis/164.4.819.

DOI:10.1093/infdis/164.4.819

PMID:1894946

Abstract

摘要

相似文献

Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression.人类免疫缺陷病毒感染患者中的脂蛋白90K：疾病进展的又一血清学标志物。

J Infect Dis. 1991 Oct;164(4):819. doi: 10.1093/infdis/164.4.819.

Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.

J Infect. 1994 Jan;28(1):31-9. doi: 10.1016/s0163-4453(94)94068-1.

90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.90K蛋白：人类免疫缺陷病毒感染中疾病进展的一种新的预测标志物。

J Acquir Immune Defic Syndr (1988). 1993 Apr;6(4):370-5.

A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.一种用于预测一组HIV-1阳性同性恋男性进展为艾滋病的90千道尔顿蛋白质血清标志物。

AIDS Res Hum Retroviruses. 1993 Sep;9(9):811-6. doi: 10.1089/aid.1993.9.811.

Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.新型循环血清90K抗原在HIV感染血友病患者中的预后价值

Br J Haematol. 1993 Sep;85(1):207-9. doi: 10.1111/j.1365-2141.1993.tb08674.x.

Unusually high level of a tumor-associated antigen in the serum of human immunodeficiency virus-seropositive individuals.

J Infect Dis. 1991 Sep;164(3):616-7. doi: 10.1093/infdis/164.3.616.

Prognostic value of a novel interferon-inducible 90K tumor antigen.一种新型干扰素诱导的90K肿瘤抗原的预后价值

Ann N Y Acad Sci. 1996 Apr 30;784:288-93. doi: 10.1111/j.1749-6632.1996.tb16243.x.

The secreted tumor-associated antigen 90K is a potent immune stimulator.分泌型肿瘤相关抗原90K是一种有效的免疫刺激剂。

J Biol Chem. 1994 Jul 15;269(28):18401-7.

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.细胞糖蛋白 LGALS3BP/90K 的抗病毒活性具有物种特异性。

J Virol. 2018 Jun 29;92(14). doi: 10.1128/JVI.00226-18. Print 2018 Jul 15.

Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.循环半乳糖凝集素-1和90K/Mac-2BP与结直肠癌患者的肿瘤分期相关。

Biomed Res Int. 2015;2015:306964. doi: 10.1155/2015/306964. Epub 2015 Sep 13.

引用本文的文献

LGALS3BP/90K suppresses porcine reproductive and respiratory syndrome virus replication by enhancing GP3 degradation and stimulating innate immunity.LGALS3BP/90K通过增强GP3降解和刺激先天免疫来抑制猪繁殖与呼吸综合征病毒的复制。

Vet Res. 2025 Jun 20;56(1):121. doi: 10.1186/s13567-025-01556-2.

Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesis.半乳糖凝集素 3 结合蛋白 (LGALS3BP) 的耗竭通过减少转化生长因子-β1 (TGF-β1) 的可用性来减轻肝纤维化，并抑制肝癌的发生。

Cancer Commun (Lond). 2024 Oct;44(10):1106-1129. doi: 10.1002/cac2.12600. Epub 2024 Jul 28.

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection.90K/LGALS3BP 的表达在 COVID-19 中上调，但可能不会限制 SARS-CoV-2 感染。

Clin Exp Med. 2023 Nov;23(7):3689-3700. doi: 10.1007/s10238-023-01077-2. Epub 2023 May 10.

Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage.宿主抗病毒因子劫持弗林蛋白酶以阻止 SARS-CoV-2、埃博拉病毒和 HIV-1 糖蛋白的切割。

Emerg Microbes Infect. 2023 Dec;12(1):2164742. doi: 10.1080/22221751.2022.2164742.

Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.Galectin-3 结合蛋白刺激 IL-6 表达可被针对 SARS-CoV-2 易感细胞系的抗体干预所抑制。

Sci Rep. 2022 Oct 11;12(1):17047. doi: 10.1038/s41598-022-20852-x.

Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.Gal-3BP 在病毒感染中的作用：严重急性呼吸综合征冠状病毒 2 中的新角色。

Int J Mol Sci. 2022 Jun 30;23(13):7314. doi: 10.3390/ijms23137314.

Severity Biomarkers in Puumala Hantavirus Infection.普马拉型汉坦病毒感染的严重程度生物标志物。

Viruses. 2021 Dec 28;14(1):45. doi: 10.3390/v14010045.

Differentiating children with sepsis with and without acute respiratory distress syndrome using proteomics.利用蛋白质组学区分患有和不患有急性呼吸窘迫综合征的脓毒症患儿。

Am J Physiol Lung Cell Mol Physiol. 2022 Mar 1;322(3):L365-L372. doi: 10.1152/ajplung.00164.2021. Epub 2022 Jan 5.

LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis.半乳糖凝集素3结合蛋白：一种与脓毒症患者诊断和预后相关的潜在血浆生物标志物。

Infect Drug Resist. 2021 Jul 24;14:2863-2871. doi: 10.2147/IDR.S316402. eCollection 2021.

Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1.Gal-3BP 通过抑制 TAK1 的激活来负调控 NF-κB 信号通路。

Front Immunol. 2019 Jul 26;10:1760. doi: 10.3389/fimmu.2019.01760. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验